title: Sudden cardiac death: opportunities for prevention.
abstract: The evidence base for implantable cardioverter-defibrillator (ICD) therapy requires expansion of guidance/indications to allow UK physicians to treat a broader range of patients. The ICD clinical consultees to the National Institute for Health and Clinical Excellence (NICE) review current guidance/guidelines, explain the evidence base, and suggest a UK ICD implantation strategy.
authors.forename: J M
authors.initials: JM
authors.lastname: Morgan
authors.forename: J C
authors.initials: JC
authors.lastname: Cowan
authors.forename: A J
authors.initials: AJ
authors.lastname: Camm
authors.forename: J M
authors.initials: JM
authors.lastname: McComb
mesh_terms: D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000191:economics; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications* / Q000191:economics; D018570:Risk Assessment; D012307:Risk Factors